ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

The Texas Heart Institute

M. Razavi

ACC 2023: Catch Them Before They Fall - Syncope Guidelines in Action

ACC 2023 Conference Coverage

B. Olshansky

HRS 2024: The Impact of CCM® on My Practice

CCM® Therapy

S. Jamal

Ischemic Ventricular Tachycardia

Scripps Health

D. Gibson

Cardiac Sarcoidosis: Improving Diagnosis and Management

Courage and Innovation Symposium: Heart Failure & Heart Transplantation

B. Chung

Harnessing IO in the Management of CSCC

Winship Cancer Institute - Emory University

N. Saba

Evaluation and Management of Heart Rhythm Disorders in Patients with…

10th Annual California Heart Rhythm Symposium

V. Vedantham

Integrating Barostim into a Comprehensive Heart Failure Program ISHL…

CVRx | Barostim

D. Yaranov, P. Patel, R. Gupta, J. Schmitto, E. Chung

Antitachycardia Pacing and VT Termination: Fact or Fancy?

Ulrika Birgersdotter-Green

Tailor LUX-Dx ICM Program Settings Remotely

Boston Scientific

D. Perschbacher

New Device for Temporary AV Sequential Pacemaker

Miami Valves 2022

C. Marin Y Kall

LUX-Dx ICM Tachycardia Algorithm

Boston Scientific

HRS 2024: Clinical Update: Future of CCM-D

CCM® Therapy

N. Varma

First Results of The Modular ATP Trial: Safety and Effectiveness of …

Boston Scientific

R. Knops

Engineered for Advance Control

Boston Scientific

D. Perschbacher, S. Vanderline, J. Kelly, S. Saha

New Options for Heart Failure Patients with Narrow QRS

CVRx | Barostim

J. Singh

Barostim Patient Identification

CVRx | Barostim

R. Canby

Unmet Needs and Device Therapies in HFrEF

CVRx | Barostim

J. Singh

Management of High Risk Squamous Cell Carcinoma

NYU Langone

M. L. Stevenson